@InvivoPartners profile picture
Invivo Partners @InvivoPartners

We are a VC fund focused on investing in early-stage companies in the healthcare sector.

Joined October 2019
  • Tweets 323
  • Following 149
  • Followers 605
84 Photos and videos
We’re proud to celebrate a major milestone from our portfolio company, EsoBiotec. Congratulations to the team for their pursuit of cutting-edge science and their commitment to improving patient outcomes. linkedin.com/feed/update/urn…
1
439
INTERNSHIP OPPORTUNITY: Are you willing to start a career in the #VentureCapital space? Apply now! 🗓Deadline: 5th December 2024!🗓 linkedin.com/feed/update/urn…
1
2
361
Invivo Partners retweeted
Hospital Clínic
@hospitalclinic
23 Oct 2024
🏥🚀 Vine a les jornades del #CampusClínicInnova 2024 on ponents destacats parlaran sobre innnovació en salut: ✔️ Disseny de sistemes de simulació en salut ✔️ Teràpies avançades ✔️ El futur de la medicina ✔️ IA en transformació digital Inscriu-t'hi 👉 i.mtr.cool/tymggnnbgb
1
9
17
2,140
EVENT: Today, @laurg87 participated in the roundtable organized by @Itemas on "The Role of Institutions in Participated Companies", alongside @AnaRodriguezC11, Rafael Mañez (@Remabtx) , and @ypuiggros (@PwC_Spain), moderated by Lluís Blanch (@Itemas) y Ramon Maspons (@AQuAScat)
ITEMAS@Itemas
29 Oct 2024
Cerramos la mañana hablando sobre el rol de las instituciones en empresas participadas con: ✅@AnaRodriguezC11 (consultora) ✅ @laurg87 (@InvivoPartners) ✅ Rafael Máñez (@Remabtx) ✅ @ypuiggros (@PwC_Spain) Moderan Lluís Blanch (ITEMAS) y Ramon Maspons (@AQuAScat)
2
5
268
Invivo Partners retweeted
ITEMAS@Itemas
29 Oct 2024
Cerramos la mañana hablando sobre el rol de las instituciones en empresas participadas con: ✅@AnaRodriguezC11 (consultora) ✅ @laurg87 (@InvivoPartners) ✅ Rafael Máñez (@Remabtx) ✅ @ypuiggros (@PwC_Spain) Moderan Lluís Blanch (ITEMAS) y Ramon Maspons (@AQuAScat)
5
10
614
EVENTS: Yesterday, Laura Rodriguez @laurg87 joined a panel on "Innovative Funding Mechanisms and Business Models in Orphan and Rare Diseases" with Catriona Crombie and James Levine, moderated by Daria Julkowska. linkedin.com/feed/update/urn…
44
Borja Ruiz, analyst at Invivo Partners, is attending Startup DeepTech Bootcamp 2024 by ACCIÓ where he is meeting innovative startups. The event is taking place at CN Barcelona, Hospitality for the 37th America's Cup, where attendees also have the opportunity to enjoy the event.
1
67
Tomorrow, Laura Rodriguez @laurg87 will participate in an exciting roundtable discussion at the Alcura Summit 2024, exploring the challenges and opportunities in the CGT landscape alongside a diverse panel of professionals in the field. linkedin.com/posts/alcura-es…
1
51
Laura Rodríguez @laurg87 will participate at the Oncology Innovation Panel with Ines Ullmo, Bettina Ernst, Ruben Sebastian-Perez & Marc Ramis, moderated by Juan R. Garcia, to discuss new technologies disrupting the oncology space at #RESIEurope24, Monday the 17th at 10 am.
1
3
131
EVENTS: Borja Ruiz, Analyst at Invivo Partners, is attending #GaliciaBiodays2024, organized by @BiogaGalicia, where he is meeting innovative startups in the biotech sector!
1
4
197
EVENTS: Join Laura Rodríguez @laurg87, Partner and Gemma Guinart @gemmagnrt, Principal at Invivo Partners, at #AseBioID24 organized by @AseBio! Ready to engage with the Spanish Biotech ecosystem!
1
4
150
EVENTS: Laura Rodríguez , Partner and Gemma Guinart, Principal at Invivo Partners are attending #BioEquity! Eager to make new connections with the Biotech community.
1
3
189
PORTFOLIO NEWS: Our portfolio company @onechaintx has announced the first patient dosed in the #CARxALL clinical trial evaluating its most advanced product, OC-1 for a rare and aggressive subtype of leukaemia.
One Chain Immunotherapeutics@onechaintx
8 May 2024
📣 Milestone Achieved! We've treated the first patient in our CARxALL trial with our most avanced product, OC-1. This marks a significant step forward in the fight against cortical T-cell acute lymphoblastic #leukemia More info here 👉 onechaintx.com/press/first-p…
1
3
160
EVENTS: Borja Ruiz, analyst at Invivo Partners is attending the second edition of the #ConnectionDay24 by @CataloniaBioHT
1
67
Yesterday, @laurg87, Partner at Invivo, participated in a roundtable with Marina Rigau (@mimarkdx) and Antoni Rosselló (@rcd_legal). The discussion, moderated by Adrià Escolà & Judit Domingo, focused on the three perspectives of an investment round. 1st #VenturesSummitVH @VHIR_
1
2
105
INTERNSHIP OPPORTUNITY: Are you willing to start a career in the #VentureCapital space? Apply now! 🗓Deadline extended to May 3rd!🗓 linkedin.com/posts/invivopar…
1
1
149
INTERNSHIP OPPORTUNITY: Are you willing to start a career in the hashtag#VentureCapital space? Our internship program is now open. Apply now! 🗓Deadline for applications: April 29th 2024. #InternshipOpportunity #VC linkedin.com/feed/update/urn…
1
3
272
PORTFOLIO NEWS: Welcome Michael Tadros, new CEO at Telomere. With his vast expertise in science, tech transfer, and biotech management, we're set to advance our gene therapy programs, targeting age-related diseases. linkedin.com/feed/update/urn…

PR Telomere | Invivo Partners

PORTFOLIO NEWS: We are thrilled to welcome Michael Tadros Ph.D. as the new CEO of Telomere Therapeutics. His extensive experience in science, technology transfer and biotech management will steer the...

linkedin.com
1
3
139
We are pleased to welcome Selwyn Ho to @peptomyc's Board of Directors. With his extensive experience in pharmaceutical and biotech industries, he brings invaluable expertise that will undoubtedly shape the company's future success. linkedin.com/feed/update/urn…

Peptomyc Appoints Selwyn Ho to its Board of Directors | Invivo Partners

We are pleased to welcome Selwyn Ho to Peptomyc's Board of Directors. With his extensive background in the pharmaceutical and biotech industries, Selwyn brings a wealth of knowledge and expertise...

linkedin.com
2
62
Today, Cinta Díez, Investment Analyst at @InvivoPartners, attended the IV Fòrum d'Inversió de la @start_ub @UniBarcelona, an exciting event supporting entrepreneurial projects and facilitating connections between emerging companies and potential investor partners.
2
56
Load more